Key stats
About FULLGOAL FD MGT CO
Home page
Inception date
Sep 16, 2022
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
Fullgoal Fund Management Co., Ltd.
ISIN
CNE100005KQ9
Tightly track the target index, pursue the minimization of tracking deviation and tracking err.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.00%
Health Technology94.74%
Transportation3.09%
Health Services0.83%
Commercial Services0.35%
Bonds, Cash & Other1.00%
Cash1.00%
Stock breakdown by region
Asia98.73%
Europe1.27%
North America0.00%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
159645 invests in stocks. The fund's major sectors are Health Technology, with 94.74% stocks, and Transportation, with 3.09% of the basket. The assets are mostly located in the Asia region.
159645 top holdings are Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class A and Changchun High-Tech Industry (Group) Co., Ltd. Class A, occupying 10.45% and 9.93% of the portfolio correspondingly.
159645 assets under management is 20.01 M CNY. It's risen 0.38% over the last month.
159645 fund flows account for −4.17 M CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 159645 doesn't pay dividends to its holders.
159645 shares are issued by Fullgoal Fund Management Co., Ltd. under the brand Fullgoal. The ETF was launched on Sep 16, 2022, and its management style is Passive.
159645 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
159645 follows the CSI Vaccine and Biotechnology Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
159645 invests in stocks.
159645 price has risen by 4.99% over the last month, and its yearly performance shows a 8.33% increase. See more dynamics on 159645 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 6.50% over the last month, showed a 11.03% increase in three-month performance and has increased by 10.75% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 6.50% over the last month, showed a 11.03% increase in three-month performance and has increased by 10.75% in a year.
159645 trades at a premium (0.07%) meaning the ETF is trading at a higher price than the calculated NAV.